1. Hu G, Lindstrom J, Jousilahti P, Peltonen M, Sjoberg L, Kaaja R, et al. The increasing prevalence of metabolic syndrome among Finnish men and women over a decade. J Clin Endocrinol Metab 2008;93:832-836.
2. Lee W-Y, Jung C-H, Park J-S, Rhee E-J, Kim S-W. Effects of smoking, alcohol, exercise, education, and family history on the metabolic syndrome as defined by the ATP III. Diabetes Res Clin Pract 2005;67:70-77.
3. Toms TE, Panoulas VF, John H, Douglas KM, Kitas GD. Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60-more than just an anti-inflammatory effect? A cross sectional study. Arthritis Res Ther 2009;11:R110.
4. Hamilton MT, Hamilton DG, Zderic TW. Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Diabetes 2007;56:2655-2667.
5. Mahdian D, Abbaszadeh-Goudarzi K, Raoofi A, Dadashizadeh G, Abroudi M, Zarepour E, et al. Effect of Boswellia species on the metabolic syndrome: A review. Iran J Basic Med Sci. 2020;23:1374-1381.
6. Saeed A, Feofanova EV, Yu B, Sun W, Virani SS, Nambi V, et al. Remnant-like particle cholesterol, low-density lipoprotein triglycerides, and incident cardiovascular disease. J Am Coll Cardiol 2018;72:156-169.
7. Galavi A, Hosseinzadeh H, Razavi BM. The effects of Allium cepa L.(onion) and its active constituents on metabolic syndrome: A review. Iran J Basic Med Sci. 2020;23:1-14.
8. Lonardo A, Ballestri S, Marchesini G, Angulo P, Loria P. Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome. Dig Liver Dis 2015;47:181-190.
9. Floreani A, Cazzagon N, Franceschet I, Canesso F, Salmaso L, Baldo V. Metabolic syndrome associated with primary biliary cirrhosis. J Clin Gastroenterol 2015;49:57-60.
10. Lim S, Kakoly N, Tan J, Fitzgerald G, Bahri Khomami M, Joham A, et al. Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta‐analysis and meta‐regression. Obe Rev 2019;20:339-352.
11. Czech MP. Insulin action and resistance in obesity and type 2 diabetes. Nat Med 2017;23:804-814.
12. Chen L, Chen R, Wang H, Liang F. Mechanisms linking inflammation to insulin resistance. Int J Endocrinol 2015; 2015:508409.
13. Watanabe M, Yokotsuka M, Yamaoka K, Adachi M, Nemoto A, Tango T. Effects of a lifestyle modification programme to reduce the number of risk factors for metabolic syndrome: a randomised controlled trial. Public Health Nut 2017;20:142-153.
14. Sanati S, Razavi BM, Hosseinzadeh H. A review of the effects of Capsicum annuum L. and its constituent, capsaicin, in metabolic syndrome. Iran J Basic Med Sci 2018;21:439-448.
15. Dehghani S, Mehri S, Hosseinzadeh H. The effects of Crataegus pinnatifida (Chinese hawthorn) on metabolic syndrome: A review. Iran J Basic Med Sci 2019;22:460-468.
16. Razavi BM, Lookian F, Hosseinzadeh H. Protective effects of green tea on olanzapine-induced-metabolic syndrome in rats. Biomed Pharmacother 2017;92:726-731.
17. Gupta SC, Prasad S, Tyagi AK, Kunnumakkara AB, Aggarwal BB. Neem (Azadirachta indica): An indian traditional panacea with modern molecular basis. Phytomedicine 2017;34:14-20.
18. Selvaraj B, Periyasamy S. Indian medicinal plants for diabetes: text data mining the literature of different electronic databases for future therapeutics. Biomed Res 2016;27:430-436.
19. Patel SM, Venkata KCN, Bhattacharyya P, Sethi G, Bishayee A. Potential of neem (Azadirachta indica L.) for prevention and treatment of oncologic diseases. Semin Cancer Biol 2016;41:100-115.
20. Biswas K, Chattopadhyay I, Banerjee RK, Bandyopadhyay U. Biological activities and medicinal properties of neem (Azadirachta indica). Curr Sci 2002;82:1336-1345.
21. Nwobodo EI. Evaluation of antilipid peroxidation and hypolipidemic potentials of Azadirachta Indica leaf aqueous extract in paracetamol-induced hepatotoxicity in wistar rats. Int J Inform Res Rev. 2017;4:3615-3619.
22. Igwenyi I, Eze A, Aja P, Elom S, Uraku A, Awoke J, et al. Cholesterol-lowering and hepatoprotective effect of fruit juice extract of Azadirachta indica on Plasmodium berghei infected mice. Int J Curr Microbiol App Sci 2017;6:3367-3375.
23. Moga MA, Bălan A, Anastasiu CV, Dimienescu OG, Neculoiu CD, Gavriș C. An overview on the anticancer activity of Azadirachta indica (Neem) in gynecological cancers. Int J Mol Sci 2018;19:3898-3924.
24. Singaravelu S, Sankarapillai J, Chandrakumari AS, Sinha P. Effect of Azadirachta indica crude bark extracts concentrations against gram-positive and gram-negative bacterial pathogens. J Pharm Bioallied Sci 2019;11:33-37.
25. Shakib Z, Shahraki N, Razavi BM, Hosseinzadeh H. Aloe vera as an herbal medicine in the treatment of metabolic syndrome: A review. Phytother Res 2019;33:2649-2660.
26. Sonkusare S, Palade PT, Marsh JD, Telemaque S, Pesic A, Rusch NJ. Vascular calcium channels and high blood pressure: pathophysiology and therapeutic implications. Vas Pharmacol 2006;44:131-142.
27. Bouallegue A, Bou Daou G, Srivastava AK. Endothelin-1-induced signaling pathways in vascular smooth muscle cells. Curr Vasc Pharmacol 2007;5:45-52.
28. Ignarro LJ, Kadowitz PJ. The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annual Rev Pharmacol Toxicol 1985;25:171-191.
29. Howden R. Nrf2 and cardiovascular defense. Oxid Med Cell Longev 2013;2013:104308.
30. Shah AJ, Gilani A-H, Hanif HM. Neem (Azadirachta indica) lowers blood pressure through a combination of Ca+ channel blocking and endothelium-dependent muscarinic receptors activation. Int J Pharmacol 2014;10:418-428.
31. Omóbòwálé TO, Oyagbemi AA, Alaba BA, Ola-Davies OE, Adejumobi OA, Asenuga ER, et al. Ameliorative effect of Azadirachta indica on sodium fluoride-induced hypertension through improvement of antioxidant defence system and upregulation of extracellular signal regulated kinase 1/2 signaling. J Basic Clin Physiol Pharmacol 2018;29:155-164.
32. Omóbòwálé TO, Oyagbemi AA, Ogunpolu BS, Ola-Davies OE, Olukunle JO, Asenuga ER, et al. Antihypertensive effect of polyphenol-rich fraction of Azadirachta indica on Nω-Nitro-L-arginine methyl ester-induced hypertension and cardiorenal dysfunction. Drug Res 2019;69:12-22.
33. Obiefuna I, Young R. Concurrent administration of aqueous Azadirachta indica (neem) leaf extract with DOCA‐salt prevents the development of hypertension and accompanying electrocardiogram changes in the rat. Phytother Res 2005;19:792-795.
34. Kochhar A, Sharma N, Sachdeva R. Effect of supplementation of Tulsi (Ocimum sanctum) and Neem (Azadirachta indica) leaf powder on diabetic symptoms, anthropometric parameters and blood pressure of non insulin dependent male diabetics. Stud EthnoMed 2009;3:5-9.
35. Tabeshpour J, Imenshahidi M, Hosseinzadeh H. A review of the effects of Berberis vulgaris and its major component, berberine, in metabolic syndrome. Iran J Basic Med Sci 2017;20:557-568.
36. Hassani FV, Shirani K, Hosseinzadeh H. Rosemary (Rosmarinus officinalis) as a potential therapeutic plant in metabolic syndrome: a review. Naunyn-Schmiedeberg’s Arch Pharmacol 2016;389:931-949.
37. Yoshino G, Hirano T, Kazumi T. Dyslipidemia in diabetes mellitus. Diabetes Res Clin Pract 1996;33:1-14.
38. Pirinccioglu AG, Gökalp D, Pirinccioglu M, Kizil G, Kizil M. Malondialdehyde (MDA) and protein carbonyl (PCO) levels as biomarkers of oxidative stress in subjects with familial hypercholesterolemia. Clin Biochem 2010;43:1220-1224.
39. El-Demerdash FM, Nasr HM. Antioxidant effect of selenium on lipid peroxidation, hyperlipidemia and biochemical parameters in rats exposed to diazinon. J Trace Elem Med Biol 2014;28:89-93.
40. Morel DW, Chisolm GM. Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J Lipid Res 1989;30:1827-1834.
41. Araujo FB, Barbosa DS, Hsin CY, Maranhão RC, Abdalla DS. Evaluation of oxidative stress in patients with hyperlipidemia. Atherosclerosis 1995;117:61-71.
42. Davignon J, Cohn JS. Triglycerides: a risk factor for coronary heart disease. Atherosclerosis 1996;124:57-64.
43. Soni H, Patel S, Patel G, Paranjape A. Evaluation of anti-diabetic activity of Glucova Active Tablet on Type I and Type II diabetic model in rats. J Ayurveda Integr Med 2014;5:97-103.
44. Bisht S, Sisodia S. Anti-hyperglycemic and antidyslipidemic potential of Azadirachta indica leaf extract in STZ-induced diabetes mellitus. J Pharm Sci Res 2010;2:622-627.
45. Hussain HEMA. Reversal of diabetic retinopathy in streptozotocin induced diabetic rats using traditional Indian anti-diabetic plant, Azadirachta indica (L.). Indian J Clin Biochem 2002;17:115-123.
46. Gutierrez RMP, Gómez YGY, Guzman MD. Attenuation of nonenzymatic glycation, hyperglycemia, and hyperlipidemia in streptozotocin-induced diabetic rats by chloroform leaf extract of Azadirachta indica. Pharmacogn Mag 2011;7:254-259.
47. Satyanarayana K, Sravanthi K, Shaker IA, Ponnulakshmi R. Molecular approach to identify antidiabetic potential of Azadirachta indica. J Ayurveda Integr Med 2015;6:165-174.
48. Gautam MK, Gangwar M, Singh SK, Goel RK. Effects of Azardirachta indica on vascular endothelial growth factor and cytokines in diabetic deep wound. Planta Med 2015;81:713-721.
49. Mutalik S, Chetana M, Sulochana B, Devi PU, Udupa N. Effect of Dianex, a herbal formulation on experimentally induced diabetes mellitus. Phytother Res 2005;19:409-415.
50. Perez-Gutierrez RM, Damian-Guzman M. Meliacinolin: a potent α-glucosidase and α-amylase inhibitor isolated from Azadirachta indica leaves and in vivo antidiabetic property in streptozotocin-nicotinamide-induced type 2 diabetes in mice. Biol Pharm Bull 2012;35:1516-1524.
51. Bangar OP, Jarald EE, Asghar S, Ahmad S. Antidiabetic activity of a polyherbal formulation (Karnim Plus). Int J Green Pharm 2009;3:211-214.
52. Dholi SK, Raparla R, Mankala SK, Nagappan K. In vivo Antidiabetic evaluation of Neem leaf extract in alloxan induced rats. J App Pharm Sci 2011;1:100-105.
53. Mgbeje BAI, Essien NA, Iwara IA, Egbung GE, Igile GO, Ebong PE. Lipid profile and hepatoprotective effects of combined leaf extracts of Azadirachta Indica (Neem) and Peristrophe bicalyculata in Alloxan-induced diabetic rats. Int J Phytomedicine 2013;5:159-162.
54. Peer PA, Trivedi PC, Nigade PB, Ghaisas MM, Deshpande AD. Cardioprotective effect of Azadirachta indica A. Juss. on isoprenaline induced myocardial infarction in rats. Int J Cardiol 2008;126:123-126.
55. Zuraini A, Vadiveloo T, Hidayat MT, Arifah A, Sulaiman M, Somchit M. Effects of neem (Azadirachta indica) leaf extracts on lipid and C-reactive protein concentrations in cholesterol-fed rats. J Nat Remedies 2006;6:109-114.
56. Wyatt SB, Winters KP, Dubbert PM. Overweight and obesity: prevalence, consequences, and causes of a growing public health problem. Am J Med Sci 2006;331:166-174.
57. Boden-Albala B, Sacco RL. Lifestyle factors and stroke risk: exercise, alcohol, diet, obesity, smoking, drug use, and stress. Curr Atheroscler Rep 2000;2:160-166.
58. Malnick SD, Knobler H. The medical complications of obesity. J Assoc Physicians 2006;99:565-579.
59. Mukherjee A, Sengupta S. Indian medicinal plants known to contain intestinal glucosidase inhibitors also inhibit pancreatic lipase activity—An ideal situation for obesity control by herbal drugs. Indian J Biotechnol 2013;12:32-39.
60. Jayakumar K, Srinivasan M, Ramesh N, Sachan A, Umesh M, Narayana K. Effect of neem leaf extract on feed intake and body weight in rats. Indian Vet J 2002;79:732-733.
61. Bogardus C, Lillioja S, Howard B, Reaven G, Mott D. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Inves 1984;74:1238-1246.
62. Dixit S, Maiya A. Diabetic peripheral neuropathy and its evaluation in a clinical scenario: a review. J Postgrad Med 2014;60:33-40.
63. Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A, et al. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 2001;50:637-642.
64. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. Jama 2002;287:2570-2581.
65. Ritz E, Rychlík I, Locatelli F, Halimi S. End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis 1999;34:795-808.
66. Hörle S, Grüner F, Kroll P. Epidemiology of diabetes-induced blindness-a review. Klin Monbl Augenheilkd 2002;219:777-784.
67. Coffey L, Gallagher P, Horgan O, Desmond D, MacLachlan M. Psychosocial adjustment to diabetes‐related lower limb amputation. Diabetic Med 2009;26:1063-1067.
68. Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther Assoc 2008;88:1322-1335.
69. Rains JL, Jain SK. Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med 2011;50:567-575.
70. Matough FA, Budin SB, Hamid ZA, Alwahaibi N, Mohamed J. The role of oxidative stress and antioxidants in diabetic complications. Sultan Qaboos Univ Med J 2012;12:5-18.
71. Pi J, Zhang Q, Fu J, Woods CG, Hou Y, Corkey BE, et al. ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function. Toxicol Appl Pharmacol 2010;244:77-83.
72. Tanaka Y, Tran POT, Harmon J, Robertson RP. A role for glutathione peroxidase in protecting pancreatic β cells against oxidative stress in a model of glucose toxicity. Proc Natl Acad Sci 2002;99:12363-12368.
73. Tadera K, Minami Y, Takamatsu K, Matsuoka T. Inhibition of α-glucosidase and α-amylase by flavonoids. J Nutr Sci Vitaminol 2006;52:149-153.
74. Tundis R, Loizzo M, Menichini F. Natural products as α-amylase and α-glucosidase inhibitors and their hypoglycaemic potential in the treatment of diabetes: an update. Mini Rev Med Chem 2010;10:315-331.
75. St Augustines T. Effects of Vernonia amygdalina on biochemical and hematological parameters in diabetic rats. Asian J Med Sci 2009;1:108-113.
76. Razavi B, Hosseinzadeh H. A review of the effects of Nigella sativa L. and its constituent, thymoquinone, in metabolic syndrome. J Endocrinol Invest 2014;37:1031-1040.
77. Akaberi M, Hosseinzadeh H. Grapes (Vitis vinifera) as a potential candidate for the therapy of the metabolic syndrome. Phytother Res 2016;30:540-556.
78. Hosseini A, Hosseinzadeh H. A review on the effects of Allium sativum (Garlic) in metabolic syndrome. J Endocrinol Invest 2015;38:1147-1157.
79. Joseph B, Jini D. Insight into the hypoglycaemic effect of traditional Indian herbs used in the treatment of diabetes. Res J Med Plant 2011;5:352-376.
80. Yaseen G, Ahmad M, Zafar M, Sultana S, Kayani S, Cetto AA, et al. Traditional management of diabetes in Pakistan: ethnobotanical investigation from traditional health practitioners. J Ethnopharmacol 2015;174:91-117.
81. Dineshkumar B, Analava M, Manjunatha M. Antidiabetic and hypolipidaemic effects of few common plants extract in type 2 diabetic patients at Bengal. Int J Diabetes Metabo 2010;18:59-65.
82. Riyanti S, Suganda AG, Sukandar EY. Dipeptidyl peptidase-IV inhibitory activity of some Indonesian medicinal plants. Asian J Pharm Clin Res. 2016;9:375-377.
83. Ezuruike U, Prieto JM. Assessment of potential herb-drug interactions among Nigerian adults with Type-2 diabetes. Front Pharmacol 2016;7:248-255.
84. Rameshrad M, Razavi BM, Ferns GA, Hosseinzadeh H. Pharmacology of dipeptidyl peptidase-4 inhibitors and its use in the management of metabolic syndrome: a comprehensive review on drug repositioning. DARU J Pharm Sci 2019;27:341-360.
85. Rameshrad M, Razavi BM, Lalau J-D, De Broe ME, Hosseinzadeh H. An overview of glucagon-like peptide-1 receptor agonists for the treatment of metabolic syndrome: A drug repositioning. Iran J Basic Med Sci 2020;23:556-568.
86. Green BD, Flatt PR, Bailey CJ. Dipeptidyl peptidase IV (DPP IV) inhibitors: a newly emerging drug class for the treatment of type 2 diabetes. Diabetes Vasc Dis Res 2006;3:159-165.
87. Hsia SH, Bazargan M, Davidson MB. Effect of Pancreas Tonic (an ayurvedic herbal supplement) in type 2 diabetes mellitus. Metabolism 2004;53:1166-1173.
88. Lenzen S. The mechanisms of alloxan-and streptozotocin-induced diabetes. Diabetologia 2008;51:216-226.
89. Dholi SK, Raparla R, Kannappan S. Synergic activity of fenugreek seeds and neem leaf extracts against alloxan induced diabetic rats. Int J PharmTech Res 2011;3:1963-1970.
90. Patil P, Patil S, Mane A, Verma S. Antidiabetic activity of alcoholic extract of Neem (Azadirachta indica) root bark. Nat J Physiol Pharm Pharmacol 2013;3:142-146.
91. Sunarwidhi AL, Sudarsono S, Nugroho AE. Hypoglycemic effect of combination of Azadirachta indica A. Juss. and Gynura procumbens (Lour.) Merr. ethanolic extracts standardized by rutin and quercetin in alloxan-induced hyperglycemic rats. Adv Pharm Bull 2014;4:613-618.
92. Shailey S, Basir SF. Protective role of Azadirachta indica against oxidative damage in skeletal and cardiac muscle of alloxan diabetic rats. Int J Pharm Sci 2012;4:471-477.
93. Shailey S, Basir SF. Strengthening of anti-oxidant defense by Azadirachta indica in alloxan-diabetic rat tissues. J Ayurveda Integ Med 2012;3:130-135.
94. Karole S, Shrivastava S, Thomas S, Soni B, Khan S, Dubey J, et al. Polyherbal Formulation Concept for Synergic Action: A Review. J Drug Deliv Ther 2019;9:453-466.
95. TK MM, TE FH, Musambil M, Mirshad P, OM FR, Vasudevan M. The effect of polyherbal formulation DIA7 on fasting blood glucose level in alloxan induced diabetic rats. Der Pharm Lett 2014;6:215-221.
96. Akhtar N, Khan BA, Majid A, Khan S, Mahmood T, Gulfishan ST. Pharmaceutical and biopharmaceutical evaluation of extracts from different plant parts of indigenous origin for their hypoglycemic responses in rabbits. Acta Pol Pharm 2011;68:919-925.
97. Khosla P, Bhanwra S, Singh J, Seth S, Srivastava R. A study of hypoglycaemic effects of Azadirachta indica (Neem) in normal and alloxan diabetic rabbits. Indian J Physiol Pharmacol 2000;44:69-74.
98. Upreti J, Ali S, Basir SF. Effect of lower doses of vanadate in combination with Azadirachta indica leaf extract on hepatic and renal antioxidant enzymes in streptozotocin-induced diabetic rats. Biol Trace Elem Res 2013;156:202-209.
99. Gupta NK, Srivastva N, Puri S, Bubber P, Puri V. Neuroprotective potential of Azadirachta indica leaves in diabetic rats. Asian J Pharm Clin Res 2017;10:243-248.
100. Atangwho IJ, Ebong PE, Egbung GE, Ani IF. Effects of co-administration of extracts of Vernonia amygdalina and Azadirachta indica on serum electrolyte profile of diabetic and non diabetic rats. Australian J Basic Appl Sci 2009;3:2974-2978.
101. Akinola OB, Caxton-Martins EA, Dini L. Chronic treatment with ethanolic extract of the leaves of Azadirachta indica ameliorates lesions of pancreatic islets in streptozotocin diabetes. Int J Morphol 2010;28;291-302.
102. Dallaqua B, Saito FH, Rodrigues T, Calderon IMP, Rudge MVC, Herrera E, et al. Treatment with Azadirachta indica in diabetic pregnant rats: negative effects on maternal outcome. J Ethnopharmacol 2012;143:805-811.
103. Atangwho IJ, Ebong PE, Eyong EU, Asmawi MZ, Ahmad M. Synergistic antidiabetic activity of Vernonia amygdalina and Azadirachta indica: Biochemical effects and possible mechanism. J Ethnopharmacol 2012;141:878-887.
104. Perez Gutierrez RM, de Jesus Martinez Ortiz M. Beneficial effect of Azadirachta indica on advanced glycation end-product in streptozotocin-diabetic rat. Pharm Biol 2014;52:1435-1444.
105. Gupta NK, Srivastva N, Bubber P, Puri S. The antioxidant potential of Azadirachta indica ameliorates cardioprotection following diabetic mellitus-induced microangiopathy. Pharmacogn Mag 2016;12: 371-378
106. Minokoshi Y, Kahn CR, Kahn BB. Tissue-specific ablation of the GLUT4 glucose transporter or the insulin receptor challenges assumptions about insulin action and glucose homeostasis. J Biol Chem 2003;278:33609-33612.
107. Kumar R, Arora V, Ram V, Bhandari A, Vyas P. Hypoglycemic and hypolipidemic effect of Allopolyherbal formulations in streptozotocin induced diabetes mellitus in rats. Int J Diabetes Mellit 2015;3:45-50.
108. Patel SS, Shah RS, Goyal RK. Antihyperglycemic, antihyperlipidemic and anti-oxidant effects of Dihar, a polyherbal ayurvedic formulation in streptozotocin induced diabetic rats. Indian J Exp Biol 2009;47:564-570.
109. Yadav D, Chaudhary AA, Garg V, Anwar MF, Rahman MM-u, Jamil SS, et al. In vitro toxicity and antidiabetic activity of a newly developed polyherbal formulation (MAC-ST/001) in streptozotocin-induced diabetic Wistar rats. Protoplasma 2013;250:741-749.
110. Bhat M, Kothiwale SK, Tirmale AR, Bhargava SY, Joshi BN. Antidiabetic properties of Azardiracta indica and Bougainvillea spectabilis: in vivo studies in murine diabetes model. Evid Based Complementary Altern Med 2011;2011:561625.
111. Kosta S, Tiwari A. Screening and assessment of anti-diabetic and reactive oxygen scavenging (ros), effects of herbs in streptozotacin induced mice. Pharmacol online 2009;3:695-704.
112. Jani DK, Goswami S. Screening of the herbal extracts to compare and investigate effect on glucose lowering and anorexic activity in wistar rats. Asian J Pharm Clin Res 2017;10:160-165.
113. Chattopadhyay R. Possible mechanism of antihyperglycemic effect of Azadirachta indica leaf extract: part V. J Ethnopharmacol 1999;67:373-376.
114. Muhtadi A, Irenka Y, Ayu WC, Hendriani R, Zuhrotun A. Hypoglycemic activity of 10 medicinal plants extract in glucose induced mice. Asian J Pharm Clin Res 2017;4:2455-3891.
115. Omobowale TO, Oyagbemi A, Ugbor F, Adejumobi O, Adedapo A, Yakubu M. Nω-Nitro-L-Arginine Methyl Ester (L-NAME) induced hypertension and cardiorenal oxidative stress: Modulatory effect of the methanolic extract of Azadirachta indica. FASEB J. 2017;31:1011.10-1011.10.
116. Adejumobi O, Omobowale T, Oyagbemi A, Ayenuro O, Ola-Davies O, Adedapo A, et al. Amelioration of sodium fluoride-induced hypertension, cardio-renal oxidative stress and genotoxicity by Azadirachta indica through antioxidant and extracellular signal-regulated kinase (ERK) 1/2 signalling. FASEB J 2017;31:843.12-843.12.
117. Koley K, Lal J. Pharmacological effects of Azadirachta indica (neem) leaf extract on the ECG and blood pressure of rat. Indian J Physiol Pharmacol 1994;38:223-225.
118. Thompson EB, Anderson CC. Cardiovascular effects of Azadirachta indica extract. J Pharm Sci 1978;67:1476-1478.
119. Kataria M, Gupta P, Gupta S. Hypolipidaemic and anti-atherogenic activity of petroleum ether extract of neem(Azadirachta indica) seed husk and kernel in streptozotocin-induced diabetic rats. Toxicol Int 2006;13:105-110.
120. Saleem T, Mumtaz U, Bashir MU, Qureshi HJ, Saleem A. Comparison of hypoglycemic effects of Azadirachta indica seeds and leaves on alloxan induced diabetes in male albino rats. Pak J Med Health Sci 2018;12:753-756.
121. Nugroho AE, Sari KRP, Sunarwidhi AL. Blood glucose reduction by combination of Andrographis paniculata (Burm. f.) Ness herbs and Azadirachta indica A. Juss leaves in alloxan-induced diabetic rats. J App Pharm Sci 2014;4:30-35.
122. Kar A, Choudhary B, Bandyopadhyay N. Comparative evaluation of hypoglycaemic activity of some Indian medicinal plants in alloxan diabetic rats. J Ethnopharmacol 2003;84:105-108.
123. Maithani A, Parcha V, Pant G, Kumar D, Dhulia I. Anti-hyperglycemic activity guided fractionation of aqueous extract of Azadirachta indica on alloxan induced diabetic rats. Int J Res Pharm Sci 2011;2:488-491.
124. Tiwari BK, Pandey KB, Jaiswal N, Abidi A, Rizvi SI. Anti-diabetic and anti-oxidative effect of composite extract of leaves of some Indian plants on alloxan induced diabetic Wistar rats. J Pharm Invest 2014;44:205-211.
125. Ebong PE, Atangwho IJ, Eyong EU, Egbung GE. The antidiabetic efficacy of combined extracts from two continental plants: Azadirachta indica (A. Juss)(Neem) and Vernonia amygdalina (Del.)(African bitter leaf). Am J Biochem Biotechnol 2008;4:239-244.
126. Nagashayana G, Jagadeesh K, Shreenivas PR. Evaluation of hypoglycemic activity of neem (Azadirachta indica) in albino rats. J Dent Med Sci 2014;13:4-11.
127. Chandra A, Mahdi AA, Ahmad S, Singh RK. Indian herbs result in hypoglycemic responses in streptozotocin-induced diabetic rats. Nutr Res 2007;27:161-168.
128. Chattopadhyay R. A comparative evaluation of some blood sugar lowering agents of plant origin. J Ethnopharmacol 1999;67:367-372.
129. Akinola OB, Dosumu OO, Akinola OS, Zatta L, Dini L, Caxton-Martins EA. Azadirachta indica leaf extract ameliorates hyperglycemia and hepatic glycogenosis in streptozotocin-induced diabetic wistar rats. Int J Phytomed 2010;2:320-331.
130. Akinola OB, Zatta L, Dosumu OO, Akinola OS, Adelaja AA, Dini L, et al. Intestinal lesions of streptozotocin-induced diabetes and the effects of Azadirachta indica treatment. Pharmacology 2009;3:872-881.
131. Gupta S, Kataria M, Gupta P, Murganandan S, Yashroy R. Protective role of extracts of neem seeds in diabetes caused by streptozotocin in rats. J Ethnopharmacol 2004;90:185-189.
132. Mishra A, Srivsatava R, Srivastava AK. Comparative antidiabetic profile of ayurvedic herbo-mineral formulation and its constituents on normal and streptozotocin-induced diabetic rats. Int J Pharm Sci Rev Res 2013;22:252-263.
133. Ansarullah BB, Patel V, Ramachandran A. Improved glucoregulation, insulin resistance and leptin levels by a polyherbal drug in high fat diet and low dose streptozotocin type 2 diabetes model. Diabetol Croat 2012;41:3-15.
134. Neeraja Kamakshi U, Srinivasa Rao D, Yamini Suvarchala K, Anusha K, Venkateswara Rao B. Comparative hypoglycemic study of Aloe vera, Murraya koenigii and Azadirachta indica. Int J Pharmacog Phytochem Res 2015;7:923-927.
135. Bakr A. Changes of hemoglobin content and glucose levels in the blood of Rattus norvegicus by water extracts of Azadirachta indica. Chin J Nat Med 2012;10:135-137.
136. Sanni O, Erukainure OL, Chukwuma CI, Koorbanally NA, Ibeji CU, Islam MS. Azadirachta indica inhibits key enzyme linked to type 2 diabetes in vitro, abates oxidative hepatic injury and enhances muscle glucose uptake ex vivo. Biomed Pharmacother 2019;109:734-743.
137. Kaur L, Han K-S, Bains K, Singh H. Indian culinary plants enhance glucose-induced insulin secretion and glucose consumption in INS-1 β-cells and 3T3-L1 adipocytes. Food Chem 2011;129:1120-1125.